COMPANY OVERVIEW

Alcresta Therapeutics is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases.

---

LOCATION

Newton, MA, USA

---

THERAPEUTIC AREAS

Gastrointestinal Disease

Rare Diseases

---

WEBSITE

https://www.alcresta.com

---

CAREER WEBSITE

https://www.alcresta.com/careers

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Dec 5, 2022

Alcresta Therapeutics Announces Move to New Corporate Headquarters in Waltham, MA

Sep 7, 2021

Alcresta Therapeutics Announces Medicare Local Coverage Determination that Confirms Coverage for RELiZORB

Jun 25, 2019

Alcresta Therapeutics Announces Publication of Consensus Statement Supporting Access to RELiZORB

Jun 17, 2019

Alcresta Therapeutics Announces Appointment of Daniel Orlando as Chief Executive Officer

Dec 28, 2018

Alcresta Therapeutics Announces that RELiZORB iMMOBILIZED LIPASE CARTRIDGE has been Issued a Permanent Medicare Billing Code (B4105) by the Centers for Medicare and Medicaid Services (CMS)

For More Press Releases

---